|
WO2021050701A1
|
|
Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
|
|
WO2020198478A1
|
|
Serotonin 5-ht2b inhibitory compounds
|
|
WO2020181024A1
|
|
Ready-to-use injectable formulations
|
|
WO2020172232A1
|
|
Palatable formulations
|
|
WO2020146338A1
|
|
Anthelmintic laboratory animal model for heartworm
|
|
CA3112432A1
|
|
Process for preparing the compound 2,2-difluoro-n-((1r,2s)-3-fluoro-1-hydroxy-1-(4-(6-(s-methylsulfonimidoyl)pyridin-3-yl)phenyl)propan-2-yl)acetamide
|
|
WO2020051106A1
|
|
Palatable antiparasitic formulations
|
|
WO2020041549A1
|
|
Microfluidic rotor device
|
|
US2020061613A1
|
|
Microfluidic rotor device
|
|
AU2019325343A1
|
|
Methods for manufacturing a microfluidic rotor device
|
|
AU2019324172A1
|
|
Microfluidic rotor device
|
|
AU2019326535A1
|
|
Systems and methods for inspecting a microfluidic rotor device
|
|
AR115357A1
|
|
EGG TRANSFER MODULE THAT HAS A FREE MOVING EJECTOR, AND ASSOCIATED SYSTEMS AND METHODS
|
|
SG11202010187RA
|
|
Endoparasitic depsipeptides
|
|
AU2019242554A1
|
|
Egg transfer module having free-moving ejector, and associated systems and methods
|
|
WO2019178601A1
|
|
Peptide vaccines against interleukin-31
|
|
AU2019200941A1
|
|
Anti-GnRH vaccine
|
|
AU2019200943A1
|
|
Vaccine against Bovine Viral Diarrhea Virus
|
|
AU2019234220A1
|
|
Interleukin-31 monoclonal antibodies for veterinary use
|
|
KR20200130696A
|
|
Anti-NGF antibodies and methods thereof
|
